Evidence map›Paper›PMID 27238836›Full record

ArticleNeuropharmacology2016

Serotonin differentially modulates excitatory and inhibitory synaptic inputs to putative sleep-promoting neurons of the ventrolateral preoptic nucleus.

Aude Sangare, Romain Dubourget, Hélène Geoffroy, Thierry Gallopin, Armelle Rancillac

Abstract read
PubMed Publisher
In one paragraph

Article in Neuropharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Sedative Effect ofBiomolecules & therapeutics · 2017
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Aude SangareBrain Plasticity Unit, ESPCI ParisTech, Paris, France; Centre National de la Recherche Scientifique, UMR 8249, France.
Romain DubourgetBrain Plasticity Unit, ESPCI ParisTech, Paris, France; Centre National de la Recherche Scientifique, UMR 8249, France.
Hélène GeoffroyBrain Plasticity Unit, ESPCI ParisTech, Paris, France; Centre National de la Recherche Scientifique, UMR 8249, France.
Thierry GallopinBrain Plasticity Unit, ESPCI ParisTech, Paris, France; Centre National de la Recherche Scientifique, UMR 8249, France.
Armelle RancillacBrain Plasticity Unit, ESPCI ParisTech, Paris, France; Centre National de la Recherche Scientifique, UMR 8249, France. Electronic address: armelle.rancillac@college-de-france.fr.
Centre National de la Recherche Scientifique · FRESPCI Paris · FRLaboratoire de Recherche Scientifique · FRParisTech · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of serotonin (5-HT) in sleep-wake regulation has been a subject of intense debate and remains incompletely understood. In the ventrolateral preoptic nucleus (VLPO), the main structure that triggers non-rapid eye movement (NREM) sleep, putative sleep-promoting (PSP) neurons were shown ex vivo to be either inhibited (Type-1) or excited (Type-2) by 5-HT application. To determine the complex action of this neurotransmitter on PSP neurons, we recorded spontaneous and miniature excitatory and inhibitory postsynaptic currents (sEPSCs, sIPSCs, mEPSCs and mIPSCs) in response to bath application of 5-HT. We established in mouse acute VLPO slices that 5-HT reduces spontaneous and miniature EPSC and IPSC frequencies to Type-1 neurons, whereas 5-HT selectively increases sIPSC and mIPSC frequencies to Type-2 VLPO neurons. We further determined that Type-1 neurons display a lower action potential threshold and a smaller soma size than Type-2 neurons. Finally, single-cell RT-PCR designed to identify the 13 serotonergic receptor subtypes revealed the specific mRNA expression of the 5-HT1A,B,D,F receptors by Type-1 neurons. Furthermore, the 5-HT2A-C,4,7 receptors were found to be equivalently expressed by both neuronal types. Altogether, our results establish that the excitatory and inhibitory inputs to Type-1 and Type-2 VLPO PSP neurons are differentially regulated by 5-HT. Electrophysiological, morphological and molecular differences were also identified between these two neuronal types. Our results provide new insights regarding the orchestration of sleep regulation by 5-HT release, and strongly suggest that Type-2 neurons could play a permissive role, whereas Type-1 neurons could have an executive role in sleep induction and maintenance.

Indexed as

AnimalsExcitatory Postsynaptic PotentialsInhibitory Postsynaptic PotentialsMaleMiceMice, Inbred C57BLMice, TransgenicOrgan Culture TechniquesPreoptic AreaReceptors, SerotoninSerotoninSleepSynaptic TransmissionReceptors, SerotoninSerotonin8-OH-DPAT (PubChem CID: 6917794)bicuculline (PubChem CID: 104871)EPSCsGal-GFP neuronsIPSCskynurinic acid (PubChem CID: 3845)noradrenaline (PubChem CID: 297812)NREMPF03246799 hydrochloride (PubChem CID 67097843)serotonin (PubChem CID: 160436)Single-cell RT-PCRtetrodotoxin (PubChem CID: 16759596)VLPO

Identifiers

PMID27238836
OpenAlexW2394515384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.